Adamax

Adamax is a research peptide developed in Russia as part of the broader family of cognitive and neuroprotective peptides that includes Semax and Selank. It is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 15-18) with a proline tail attached for stability — structurally similar to Semax but with a slightly different modification. Like its sibling peptides, it was developed in academic research institutes and is studied in Eastern European literature for its effects on cognition, attention, and stress resilience. It is sold strictly for laboratory use.

Adamax sits in the same family tree as Semax and Selank — peptides originally engineered in Russian neuroscience labs to support focus, memory, and stress tolerance. If Semax is the focus peptide and Selank is the calm peptide, Adamax is the lesser-known cousin that researchers describe as combining a bit of both: a steady, alert kind of mental state rather than stimulation or sedation. Online, it shows up most often in conversations about 'next-generation Semax alternatives' from biohackers who have already tried the more popular options.

Adamax shares its core sequence with Semax — both derive from the non-hormonal ACTH 4-10 region — but with a different terminal modification. The proposed mechanism involves modulation of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and the balance of dopaminergic and serotonergic signaling in the prefrontal cortex and hippocampus. As a melanocortin-derived peptide, it does not significantly stimulate the adrenal axis, which is why it is studied as a 'non-hormonal' neuropeptide.

• •Working memory and attention research
• •BDNF and NGF expression studies
• •Stress adaptation and anxiolytic profiles
• •Comparative research with Semax and Selank
• •Neuroprotection in oxidative stress models

Adamax is a deep-cut peptide on the nootropics internet. Most threads on r/Nootropics and r/Peptides describe it as a 'Semax with a smoother edge' — users comparing intranasal Semax, Selank, and Adamax often place Adamax in the middle: more focus than Selank, less stimulation than Semax. It does not have the brand recognition of either, and supply is less consistent. Researchers cite mostly Russian-language sources, which limits its mainstream visibility.

“Semax's mellower cousin.”

The most-discussed combination is Adamax + Selank for daytime focus paired with low-key stress reduction, or Adamax + Noopept in classic nootropic stacks. Some users alternate Adamax with Semax cycles to reduce tolerance to either.

Adamax is a Russian-developed research peptide in the ACTH-derived nootropic family alongside Semax and Selank. It is studied for attention, memory, and BDNF/NGF expression, and is typically administered intranasally for laboratory research only.